| Title： | Dai medicine prevention and treatment of LongShaHou (gout) expert consensus |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | This specification is applicable to guide the medical personnel of Dai medicine, traditional Chinese medicine, traditional Chinese medicine and integrated Chinese and Western medicine in ethnic medicine hospitals, Chinese medicine hospitals, integrated Chinese and Western medicine hospitals, general hospitals and primary hospitals, etc., to refer to this Consensus in their clinical practice and to provide a more comprehensive and individualized treatment plan for patients with gout. |
| Evidence classification method： | Evidence search combined with expert consensus |
| Development unit： | Yunnan Provincial Hospital of Traditional Chinese Medicine (the First Affiliated Hospital of Yunnan University of Chinese Medicine), Xishuangbanna Dai Medical Hospital, China-Japan Friendship Hospital, the First Affiliated Hospital of Tianjin University of Chinese Medicine, the First Affiliated Hospital of Nanchang University, the Third Affiliated Hospital of Beijing University of Chinese Medicine, Gansu Provincial Hospital of Traditional Chinese Medicine |
| Registration time: | 2024-10-07 |
| Registration number： | PREPARE-2024CN748 |
| Purpose of the guideline: | Dai medicine has unique advantages and clinical efficacy in the prevention and treatment of gout, but no standardized expert consensus on the prevention and treatment of gout has been established yet. This expert consensus aims to give full play to the characteristic advantages of Dai medicine, standardize the clinical practice of Dai medicine in the prevention and treatment of gout, guide physicians in clinical decision-making, and enhance the influence and recognition of Dai medicine. |
Latest registration
